Over 18 months, ischaemic optic neuropathy occurred in roughly 8.5 per 10,000 GLP-1 users, compared with about 5.5 per 10,000 among those taking SGLT2 inhibitors
Type 2 diabetes trial (Rosenstock et al., 2023) The companion paper, Rosenstock et al., 2023, ran 281 adults with type 2 diabetes for 36 weeks
Glutathione is a molecule made by the body that plays a starring role in many metabolic processes
His wife, Terri DeNeui, a nurse practitioner and founder of their company Evexias Health Solutions, presented information from a survey of 508 patients treated with various peptides that said 19% reported uncomfortable side effects and less than 1% experienced an adverse event
Side effects and safety at microdose levels The side effect profile at microdose levels is fundamentally different from full-dose therapy
a , The potency of unlabeled GLP-1(9-36) to displace [ 125 I]GLP-1(7-36) binding to the GLP-1R was measured at different concentrations of LSN3160440
